Contrarius Investment Management 13F, Q1 2025

Contrarius Group · quarter ending 31 March 2025 · filed 12 May 2025 · SEC CIK 2054801

$1.46B
Filed US book
49
Positions
11.4%
Largest position

Common stock only: shares the fund reported owning at the quarter end, valued as filed.

Largest positions, Q1 2025

The 25 largest of 49 positions. Weights are against the whole filed book. Changes are in shares held, against the Q4 2024 filing.

CompanyTickerValue% of bookvs Q4 2024
PARAMOUNT GLOBAL$166.36M11.4%unchanged
WARNER BROS DISCOVERY INCWBD$160.42M11.0%-7% shares
TESLA INCTSLA$158.41M10.8%+47% shares
NVIDIA CORPORATIONNVDA$76.38M5.2%new
FOX CORPFOX$66.15M4.5%unchanged
CAESARS ENTERTAINMENT INC NECZR$60.63M4.1%+150% shares
BARRICK GOLD CORP$58.83M4.0%+1878% shares
PENN ENTERTAINMENT INCPENN$58.66M4.0%+104% shares
CROCS INCCROX$54.81M3.8%+803% shares
COTY INCCOTY$52.50M3.6%new
HIMS & HERS HEALTH INCHIMS$51.71M3.5%new
IAC INCPPLI$50.59M3.5%new
DRAFTKINGS INC NEWDKNG$40.55M2.8%-22% shares
COINBASE GLOBAL INCCOIN$39.54M2.7%+23% shares
UNITY SOFTWARE INCU$39.06M2.7%new
ALIBABA GROUP HLDG LTDBABA$31.02M2.1%-41% shares
JD.COM INCJD$29.03M2.0%-32% shares
CELSIUS HLDGS INCCELH$23.39M1.6%-77% shares
BAIDU INCBIDU$20.31M1.4%-32% shares
PAYPAL HLDGS INCPYPL$15.22M1.0%-76% shares
INTELLIA THERAPEUTICS INCNTLA$14.37M1.0%+100% shares
VICTORIAS SECRET AND COVSXY$13.62M0.9%new
PDD HOLDINGS INCPDD$12.66M0.9%+3% shares
CRISPR THERAPEUTICS AG$11.30M0.8%-10% shares
EQT CORPEQT$11.19M0.8%-31% shares

What changed since Q4 2024

Against the Q4 2024 filing, Contrarius Investment Management opened 12 new positions, added to 10, trimmed 22, left 5 unchanged and exited 5. Every position is compared, matched on its CUSIP; a change of 2% or less in shares counts as unchanged.

New positions

and 4 more

Exited

Added to

  • TSLA+47%$158.41M
  • CZR+150%$60.63M
  • BARRICK GOLD CORP+1878%$58.83M
  • PENN+104%$58.66M
  • CROX+803%$54.81M
  • COIN+23%$39.54M
  • NTLA+100%$14.37M
  • PDD+3%$12.66M

and 2 more

Trimmed

  • WBD-7%$160.42M
  • DKNG-22%$40.55M
  • BABA-41%$31.02M
  • JD-32%$29.03M
  • CELH-77%$23.39M
  • BIDU-32%$20.31M
  • PYPL-76%$15.22M
  • CRISPR THERAPEUTICS AG-10%$11.30M

and 14 more

Other quarters

Source: SEC Form 13F-HR, accession 0001999371-25-005829, filed by Contrarius Group Holdings Ltd. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.